Cashu
Skye Bioscience Faces Class Action Lawsuits Over Alleged Drug Efficacy Misrepresentations
about 1 month ago
Stocks
Health Care
skye
Skye Bioscience
NASDAQ: SKYE
+0.02 (+2.60%)
0.755
USD
At close at Mar 04, 21:41 UTC
Latest Skye Bioscience News
prnewswire.com
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE
about 2 months ago
prnewswire.com
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
about 2 months ago
prnewswire.com
SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit
about 2 months ago
prnewswire.com
Class Action Filed Against Skye Bioscience, Inc. (SKYE) - January 16, 2026 Deadline to Join - Contact The Gross Law Firm
about 2 months ago
prnewswire.com
Levi & Korsinsky Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - SKYE
about 2 months ago
prnewswire.com
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE
about 2 months ago
prnewswire.com
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
about 2 months ago
prnewswire.com
FRIDAY DEADLINE: Berger Montague Advises Skye Bioscience, Inc. (NASDAQ: SKYE) Investors to Inquire About a Securities Fraud Class Action by January 16, 2026
about 2 months ago
prnewswire.com
SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit
about 2 months ago
prnewswire.com
Investors who lost money on Skye Bioscience, Inc.(SKYE) should contact Levi & Korsinsky about pending Class Action - SKYE
about 2 months ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.